LY300503
Product Specifications
UNSPSC Description
LY300503 is an enantiomer of LY191704. LY191704 is a human type I 5α-reductase inhibitor[1][2].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/ly300503.html
Solubility
10 mM in DMSO
Smiles
CN1[C@]2([H])[C@](CCC1=O)([H])C3=CC=C(Cl)C=C3CC2
Molecular Weight
249.74
References & Citations
[1]Farid NA, et, al. High-performance liquid chromatographic determination of the enantiomers of the benzoquinolinone LY191704, a human type 1 5 alpha-reductase inhibitor, in plasma. J Chromatogr B Biomed Sci Appl.|[2]Farid NA, et, al. Stereoselective disposition of the enantiomers of the benzoquinolinone LY191704, a human type I 5 alpha-reductase inhibitor. Differences between rats and dogs. Drug Metab Dispos. 1996 Oct;24(10):1162-5.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-118091B/LY300503-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-118091B/
Clinical Information
No Development Reported
CAS Number
148905-79-7
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6012451-01 0.1 mg
DC-SIGN, CT (Dendritic Cells, CD209, Dendritic Cell-Specific ICAM-3, SIGNR1, SIGN-R1)
Ask
View Details MBS6012451-02 5x 0.1 mg
DC-SIGN, CT (Dendritic Cells, CD209, Dendritic Cell-Specific ICAM-3, SIGNR1, SIGN-R1)
Ask
View Details 
